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Abstract
 
The intracellular protozoan parasite 
 
Trypanosoma cruzi
 
 causes Chagas’ disease, which affects mil-
lions of people in Latin America. 
 
T. cruzi
 
 enters a large number of cell types by an unusual
mechanism that involves Ca
 
2
 
1
 
-triggered fusion of lysosomes with the plasma membrane. Here
we show that synaptotagmin VII (Syt VII), a ubiquitously expressed synaptotagmin isoform
that regulates exocytosis of lysosomes, is localized on the membranes of intracellular vacuoles
containing 
 
T. cruzi
 
. Antibodies against the C
 
2
 
A domain of Syt VII or recombinant peptides in-
cluding this domain inhibit cell entry by 
 
T. cruzi
 
, but not by 
 
Toxoplasma gondii
 
 or 
 
Salmonella ty-
phimurium
 
. The C
 
2
 
A domains of other ubiquitously expressed synaptotagmin isoforms have no
effect on 
 
T. cruzi
 
 invasion, and mutation of critical residues on Syt VII C
 
2
 
A abolish its inhibi-
tory activity. These findings indicate that 
 
T. cruzi
 
 exploits the Syt VII–dependent, Ca
 
2
 
1
 
-regu-
lated lysosomal exocytic pathway for invading host cells.
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Introduction
 
Human infection with 
 
Trypanosoma cruzi
 
 is prevalent in ex-
tensive areas of South and Central America, where more
than 15 million people are estimated to be chronically in-
fected. The acute phase of the infection is often fatal in
children, and survivors frequently develop serious condi-
tions such as cardiomyopathy and megacolon, which can
lead to premature death. A large number of wild animals
serve as reservoirs for 
 
T. cruzi
 
, and this broad host range
correlates well with the parasite’s ability to invade and rep-
licate inside a large variety of mammalian cell types.
Previous studies revealed that infection of fibroblasts
and epithelial cells by trypomastigotes, the infective forms
of 
 
T. cruzi,
 
 occurs by an unusual mechanism, distinct from
phagocytosis. Parasite entry is independent of host cell ac-
tin polymerization and requires mobilization of host cell
lysosomes to the invasion site (1, 2). Time-lapse imaging
of the invasion process revealed a directional movement
and clustering of lysosomes at the site of trypomastigote
attachment, followed by progressive fusion of lysosomes
with the plasma membrane as the parasites entered the cell
(3). Recently and partially internalized trypomastigotes are
found in acidic intracellular vacuoles containing lysosomal
markers, strongly suggesting that the parasite-containing
compartment is formed through lysosomal fusion (2). A
trypomastigote-triggered signaling cascade resulting in a
localized elevation of the host cell intracellular free Ca
 
2
 
1
 
concentration ([Ca
 
2
 
1
 
]
 
i
 
) is also required for cell invasion
and for the efficient establishment of infections in mice
(4–7). Thus, the 
 
T. cruzi
 
 cell entry process has several fea-
tures that resemble regulated exocytosis: it involves eleva-
tion in [Ca
 
2
 
1
 
]
 
i 
 
and mobilization of lysosomes to the plasma
membrane, followed by fusion.
The similarities between the 
 
T. cruzi
 
 invasion process
and regulated exocytosis led us to investigate a possible role
for synaptotagmin VII (Syt VII), a ubiquitously expressed
member of the synaptotagmin family previously implicated
in the regulation of lysosomal exocytosis (8). Synaptotag-
mins are transmembrane proteins with a short NH
 
2
 
-termi-
nal ectodomain, a single transmembrane region, and two
highly conserved, independently folding Ca
 
2
 
1
 
-binding C
 
2
 
domains (C
 
2
 
A and C
 
2
 
B) homologous to the C
 
2
 
 regulatory
region of protein kinase C. Genetic studies in mice, 
 
Dro-
sophila
 
, and
 
 Caenorhabditi elegans
 
 revealed that synaptotagmin
I (Syt I), which is present on the membranes of synaptic
vesicles in neurons, is essential for normal Ca
 
2
 
1
 
-dependent
neurotransmitter release (9, 10). The C
 
2
 
A domains of Syt I
and of several additional isoforms interact with the
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t-SNARE (soluble 
 
N
 
-ethylmaleimide–sensitive factor at-
tachment protein receptor) syntaxin and with acidic phos-
pholipids in a Ca
 
2
 
1
 
-dependent manner, albeit with slightly
different properties (11). A Ca
 
2
 
1
 
-dependent interaction was
also detected between the C
 
2
 
A domain of Syt I and SNAP-
25 (12), another core component of the conserved
SNARE membrane fusion “machine” (13). Although sev-
eral of the 12 rat and mouse synaptotagmin isoforms de-
scribed to date are primarily found in brain, some are also
expressed in other tissues (11, 14). Syt VII, in particular, is
expressed at significant levels on most mouse tissues (15).
Consistent with this ubiquitous pattern of expression, re-
cent work from our laboratory showed that Syt VII is lo-
calized on the membrane of lysosomes in NRK cells (8).
Recently proposed models for the role of Syt I in synap-
tic vesicle exocytosis suggest that Ca
 
2
 
1
 
-triggered interac-
tions involving the C
 
2
 
 domains alter the physical relation-
ship between the SNARE complex and the lipid bilayers,
facilitating fusion (12, 16). In particular, several lines of evi-
dence indicate that the C
 
2
 
A domain is central for the func-
tion of synaptotagmins in the regulation of Ca
 
2
 
1
 
-triggered
exocytosis (12, 17–20). Antibodies generated against the
Syt I C
 
2
 
A domain and recombinant peptides containing the
Syt I C
 
2
 
A domain are powerful inhibitors of Ca
 
2
 
1
 
-triggered
exocytosis when introduced into neuronal cells (18–20).
Similarly, the C
 
2
 
A domain of Syt VII or antibodies to this
domain efficiently block Ca
 
2
 
1
 
-triggered exocytosis of lyso-
somes in permeabilized NRK cells (8). Importantly, inhibi-
tion of lysosomal exocytosis in NRK cells is only observed
in the presence of the Syt VII C
 
2
 
A domain, and not the
C
 
2
 
A domain of the exclusively neuronal isoform Syt I (8).
These observations indicate that Syt VII functions as a spe-
cific regulator of lysosomal exocytosis, which is triggered at
low micromolar [Ca
 
2
 
1
 
]
 
i
 
 in several cell types (21–23). In this
report, we show that modulation of Syt VII function inhib-
its host cell invasion by 
 
T. cruzi
 
, strongly suggesting that
this parasite utilizes the Ca
 
2
 
1
 
-regulated lysosomal exocytic
pathway for establishing intracellular infections.
 
Materials and Methods
 
Antibodies, Western Blot, and Immunofluorescence.
 
Polyclonal
antibodies against the Syt VII NH
 
2
 
-terminal ectodomain were
generated by immunization of a rabbit with the synthetic peptide
MYRDPEAASPGAC and purified as described previously (8).
Rabbit polyclonal antibodies against 
 
Escherichia coli
 
–expressed Syt
VII C
 
2
 
A domain were also generated and affinity purified as pre-
viously described (8). For Western blots, extracts of NRK (rat),
Hela, HEK-293 (human), 3T3 (mouse), and CHO (hamster) cells
were prepared in 150 mM NaCl, 50 mM Tris, pH 8.6, and 1%
NP-40 containing protease inhibitors. 20 
 
m
 
g of cell extract was
loaded on each lane for SDS-PAGE, transferred to immobilon fil-
ters, and probed with purified anti–Syt VII IgG followed by ECL
(New England Nuclear) detection (9). Immunofluorescence as-
says were performed on HEK-293 and 3T3 cells fixed in 100%
methanol at 20
 
8
 
C for 10 min and rehydrated in PBS for 30 min,
followed by anti–Syt VII rabbit IgG (8) and a mouse mAb to hu-
man Lamp-1 (H4A3) or a rat mAb to mouse Lamp-1 (1D4B; De-
velopmental Studies Hybridoma Bank, Iowa City, IA). CHO
cells were fixed in 2% paraformaldehyde, incubated for 15 min in
50 mM NH
 
4
 
Cl, permeabilized with 0.1% Triton X-100 for 30
min, and incubated with rabbit anti–Syt VII and a mouse mAb to
hamster Lamp-1 (UH1), followed by the appropriate secondary
antibodies (goat anti-rabbit, -mouse, or -rat conjugated to Alexa
488 or 546; Molecular Probes). Images were acquired in a Zeiss
Axiovert 135 microscope through a 100
 
3
 
 objective using a
Hamamatsu Orca II cooled CCD camera, controlled by Meta-
morph software (Universal Imaging).
 
Reverse Transcription PCR, Site-directed Mutagenesis, and Transfec-
tions.
 
cDNA was synthesized from 10 
 
m
 
g of total RNA previ-
ously treated with Rnase-free Dnase I (GIBCO BRL). Forward
and reverse primers used for reverse transcription (RT)-PCR
amplification of the synaptotagmin C
 
2
 
A domains were designed
based on nonconserved regions encoded by two separate exons of
the individual rat DNA sequences and were as follows: 5
 
9
 
-GAG-
GAGAAACTGGGAAAGCTC-3
 
9
 
 (forward) and 5
 
9
 
-TTTCT-
CAGCGCTCTGGAGAT-3
 
9
 
 (reverse) for Syt I C
 
2
 
A, 5
 
9
 
-GAA-
AGAGCCGGAGAACCTGG-3
 
9
 
 (forward) and 5
 
9
 
-ATT-
CCTCGATGGGCTGGCCAAG-3
 
9
 
 (reverse) for Syt II C
 
2
 
A,
5
 
9
 
-CTTGCCCAGTGCCCAGTCTCATC-3
 
9
 
 (forward) and
5
 
9
 
-AGAGTGGACGGTCAGGGGGCTGTTC-3
 
9
 
 (reverse) for
Syt III C
 
2
 
A, 5
 
9
 
-CAAGAGAAGCTGGGCACTCTC-3
 
9
 
 (for-
ward) and 5
 
9
 
-GGTCATTAACATTTTCCCGTCTGAC-3
 
9
 
 
 
(re-
verse) for Syt IV C
 
2
 
A, 5
 
9
 
-GCAAGAGCTGTGGGAAGATC-
AAC-3
 
9
 
 (forward) and 5
 
9
 
-AGATGGAGGTCTCCCGGGAC-3
 
9
 
(reverse) for Syt VI C
 
2
 
A, 5
 
9
 
-AGCCGAGAGAACCTG-3
 
9
 
 (for-
ward) and 5
 
9
 
-ATGGGAGTGGGAGCCGAG-3
 
9
 
 (reverse) for
Syt VII C
 
2
 
A, 5
 
9
 
-TGCTCTGGAGGGGACCAACAG-3
 
9
 
 (for-
ward) and 5
 
9
 
-ACCAGCTCTCCAGGACATGTTG-3
 
9
 
 (reverse)
for Syt VIII C
 
2
 
A, and 5
 
9
 
-CAGGTATTGGACAAGCAC-
CAG-3
 
9
 
 (forward) and 5
 
9
 
-TGAACTCATAGGCACCCGCAC-3
 
9
 
(reverse) for Syt IX C
 
2
 
A.
The amplified products were first cloned into blunt-ended
pBluescript plasmid and then into the EcoRI site of the pEGFP-
N2 vector (Clontech). PCR-based site-directed mutagenesis re-
actions (Stratagene) were used to generate point mutations in the
Syt VII C
 
2
 
A domain, using the C
 
2
 
A–pEGFP fusion plasmid as
template. For mutations of aspartate residues to asparagines
(D166N/D172N/D225N/D227N), two rounds of PCR
mutagenesis were done using the following primers: 5
 
9
 
-
AGGCCCAGGAGCTGCCGGCCAAGAACTTCAGTGGC-
ACTAGTAACCCCTTTGTCAAGATCTACC-3
 
9
 
 and 5
 
9
 
-
TCCGGGTCCTCGACGGCCGGTTCTTGAAGTCACCG-
TGATCATTGGGGAAACAGTTCTAGATGG-3
 
9 
 
for the first
round and 5
 
9-TCTACCTCCAGGTCCTGAACTATACCGT-
TTCAGCCGCAATG-39 and 59-AGATGGAGGTCCAGGA-
CTTGATATTGGCAAAGTCGGCGTAC-39 for the second
round. The plasmid harboring the aspartate mutations was then
used as template to replace the KKHK domain (K183A/K184A/
H185A/K186A) using the following primers: 59-ATC-
TACCTACTACCCGACGCGGCGGCGGCGCTGGAGAC-
CAAGGTGAAAC-39 and 59-TAGATGGATGATGGGCT-
GCGCCGCCGCCGCGACCTCTGGTTCCACTTTG-39. All
C2A–green fluorescent protein (GFP) mutant constructs were
checked by sequencing and transiently expressed for functional
studies.
Cell transfections were performed with 2 mg total DNA us-
ing FuGENE 6 (Boehringer Mannheim) on cells plated at 50%
confluency 24 h before. Infections with T. cruzi, Toxoplasma,
or Salmonella were done 24 h after transfection, when the
fraction of cells showing cytosolic expression of GFP was
z20–30%.1099 Caler et al. Brief Definitive Report
Quantitation of GFP Expression Levels. The average GFP flu-
orescence intensity associated with transfected cells was measured
on 8-bit data mode images acquired through a 1003 objective
with a Hamamatsu Orca II cooled CCD camera, controlled by
Metamorph imaging software (Universal Imaging). The focal
plane and outline of each cell was initially established by phase–
contrast observations. Fluorescent images were acquired for 50
ms without autoscale, under conditions that ensured linear dy-
namic range detection of E-GFP emission at 507 nm. Individual
cells on the images were outlined, and average fluorescence in-
tensity values for each outlined region were obtained using the
Metamorph “region statistics” function. Background fluores-
cence intensity values were acquired in an identical area of the
same microscopic field containing no transfected cells and sub-
strated from each value obtained for transfected cells. For each
transfection group (GFPv, Syt I C2A–GFP, Syt VII C2A–GFP,
Syt VIII C2A–GFP, Syt IX C2A–GFP, and mutated Syt VII
C2A–GFP [mSyt VII C2A]), measurements were made in 40 ran-
domly chosen individual cells. Cells expressing very high or very
low levels of GFP, previously determined by eye examination,
were excluded from the analysis.
Glass Bead Antibody Loading. Confluent monolayers of
NRK cells were plated on 12-mm round coverslips 48 h before
the experiment. Coverslips were rinsed in PBS21 (containing
Ca21 and Mg21) on a heated stage at 378C and covered with 50
ml of PBS21 containing 5 mg/ml Texas Red–dextran and 20
mg/ml affinity-purified rabbit anti–Syt VII C2A or preimmune
rabbit IgG. The cells were then sprinkled with 0.05 g (z200
beads) of acid-washed glass beads (425–600 mm; Sigma-Aldrich)
from a culture tube held 1–3 cm above the coverslip (24). The
coverslips were gently rocked four times to let the beads roll
over the cells, rinsed in PBS21, and exposed to T. cruzi trypo-
mastigotes.
Microinjection. Microinjection of NRK and CHO cells was
performed on a Zeiss Axiovert 135 microscope equipped with a
heated stage, using an Eppendorf micromanipulator 5170 and mi-
croinjector 5242. Histidine (his)-tagged constructs of Syt VII and
Syt I C2A were expressed in E. coli, purified (8), and concentrated
to 1 mg/ml in microinjection buffer (27 mM K2HPO4, 8 mM
Na2HPO4, and 26 mM KH2PO4, pH 7.2) containing 1 mg/ml
10,000 MW Texas Red–dextran to visualize injected cells. Ap-
proximately 500 cells were microinjected in each experiment,
Figure 1. Syt VII is localized on the membranes of
lysosomes and of T. cruzi–containing intracellular
vacuoles. (A) Detection of Syt VII on extracts of dif-
ferent cell types by Western blot using antibodies
specific for the unique NH2-terminal Syt VII
ectodomain. (B) Double immunofluorescence show-
ing colocalization of Syt VII (red) and the lysosomal
glycoprotein Lamp-1 (green) in HEK-293, 3T3, and
CHO cells. Arrows point to examples of compart-
ments double positive for Syt VII and Lamp-1. (C)
Double immunofluorescence showing colocalization
of Syt VII (red) and Lamp-1 (green) on the mem-
branes of intracellular vacuoles containing T. cruzi
(arrows). DAPI staining of host cell and parasite
DNA is shown in blue.1100 Cell Entry by Trypanosoma cruzi Is Regulated by Synaptotagmin VII
followed by incubation at 378C in a 5% CO2 atmosphere for 1 h
before exposure to parasites.
Cell Invasion Assays. T.  cruzi invasion assays of NRK and
CHO cells were performed by exposing cells plated 48 h before
(104 cells/cm2) to 5 3 107 trypomastigotes per milliliter in
DMEM 2% FBS for 1 h at 378C. After PBS washes and 2%
paraformaldehyde fixation, the number of intracellular and extra-
cellular trypomastigotes associated with cells was determined by
immunofluorescence, as previously described (2). For T. gondii
invasion assays, 5 3 107 parasites per milliliter were added to
CHO cells plated as above and incubated at 378C for 1 h. After
PBS washes and fixation in 100% methanol for 1 min, intracellu-
lar parasites were quantitated by immunofluorescence using the
mAb T62H11 specific for the dense granule protein GRA3,
which is incorporated into the parasitophorous vacuole mem-
brane during invasion (25). Invasion and immunofluorescent
quantitation of intracellular S. typhimurium strain SL1344 after a
30-min infection of CHO cells was done as described (26). In all
experiments, cells expressing very high or very low levels of GFP,
as determined by fluorescence microscopy examination, were ex-
cluded from analysis. In all assays, a minimum of 200 transfected
cells was analyzed for each point, and results were normalized to
parasites per 100 cells.
Results and Discussion
As mentioned above, T. cruzi invades a large variety of
vertebrate cells, through a mechanism involving early in-
teraction with host lysosomes. Previous studies showed that
the synaptotagmin isoform Syt VII is localized on the
membrane of lysosomes of NRK cells, where it regulates
Ca21-triggered exocytosis (8). Thus, to investigate a possi-
ble role for Syt VII on T. cruzi invasion, it was first neces-
sary to verify if Syt VII was also present on the membranes
of lysosomes of additional cell types. A protein with the ex-
pected migration in SDS-PAGE for Syt VII (z65 kD) was
detected on extracts of different cell types (human, rat,
mouse, and hamster) with antibodies against the unique
NH2-terminal domain of Syt VII (Fig. 1 A). In immuno-
fluorescence assays, Syt VII was found to colocalize with the
lysosomal marker Lamp-1 in human HEK293, mouse 3T3,
hamster CHO (Fig. 1 B), human HeLa, and mouse L cells
(not shown). Taken together with the previous detailed
characterization of Syt VII expression in NRK cells (8),
these results indicate that Syt VII is present on the mem-
branes of lysosomes of a large variety of mammalian cell
types. Immunofluorescence of T. cruzi–infected CHO cells
with specific anti–Syt VII antibodies also demonstrated that
this isoform is incorporated into the membranes of recently
formed intracellular vacuoles containing trypomastigotes
(Fig. 1 C). Very similar images (not shown) were obtained
in NRK cells transfected with an expression plasmid en-
coding full-length Syt VII fused to GFP, previously shown
to be targeted to lysosomes (8).
To investigate whether modulation of Syt VII function
had an effect on T. cruzi invasion, affinity-purified antibod-
ies against the Syt VII C2A domain were introduced into
the cytosol of CHO cells by glass bead loading. In this pro-
cedure, wounds created on the plasma membrane by con-
tact with the glass beads are rapidly resealed at 378C in the
presence of Ca21, trapping extracellularly added molecules
inside the cells (24). Previous studies in NRK cells showed
that these anti–Syt VII C2A antibodies, when added to
streptolysin O–permeabilized cells, are effective inhibitors
of the exocytosis of lysosomes triggered by 1 mM Ca21 (8).
As shown in Fig. 2, a marked inhibition was observed on
T. cruzi invasion of CHO cells loaded with anti–Syt VII
C2A antibodies. Whereas trypomastigotes entered normally
unloaded cells or cells loaded with preimmune rabbit IgG,
a reduction in the number of intracellular parasites of
z50% was observed in cells preloaded with anti–Syt VII
C2A antibodies (Fig. 2, A–C).
Earlier studies showed that soluble recombinant con-
structs containing the C2A domain of Syt VII also inhibit
Ca21-dependent exocytosis of lysosomes in permeabilized
Figure 2. Antibodies against the Syt VII C2A domain inhibit cell inva-
sion by T. cruzi. (A) DAPI DNA stain (left) and Texas Red–dextran
(right) fluorescent images of CHO cells loaded with preimmune rabbit
IgG. Arrows point to infected cells previously loaded with dextran and
IgG. (B) Same as A, except that the cells were loaded with affinity-puri-
fied antibodies against the Syt VII C2A domain. Arrowheads point to un-
infected cells previously loaded with dextran and IgG. (C) Quantitation
of the number of intracellular trypomastigotes found in cells loaded (black
bars) or unloaded (white bars) with dextran, in the presence of PBS only
or of preimmune (PI) or anti–Syt VII C2A antibodies (a-C2A). The data
is expressed as the mean 6 SD of triplicate infections.1101 Caler et al. Brief Definitive Report
cells in a dose-dependent manner. Equivalent constructs
containing the C2A domain of Syt I, the exclusively neu-
ronal isoform, have no effect (8). To verify if a similar ef-
fect was observed with T. cruzi invasion, CHO cells were
transiently transfected with vectors encoding GFP-tagged
constructs of Syt I C2A and Syt VII C2A or GFP alone.
The GFP expression levels 24 h after transfection were de-
termined by image analysis as described in Materials and
Methods and found to be within a similar range (Table I).
When the number of intracellular trypomastigotes was
evaluated, no statistically significant difference was found
between the number of intracellular parasites in untrans-
fected and in GFPv- and Syt I C2A–GFP-transfected cells
(P 5 0.7906, one-way analysis of variance test). In contrast,
an extremely significant inhibition of T. cruzi entry was ob-
served in Syt VII C2A–GFP-transfected cells (P 5 0.0001,
unpaired Student’s t test; Fig. 3 A). Taken together with
the inhibitory effect of anti–Syt VII C2A antibodies (Fig. 2
C), these results strongly suggest that the C2A domain of
Syt VII interferes specifically with the T. cruzi cell invasion
process, similar to what is observed with Ca21-triggered
exocytosis of lysosomes.
We thus proceeded to verify whether invasion by intra-
cellular pathogens different from T. cruzi, which enter host
cells by mechanisms not involving Ca21-dependent lyso-
some recruitment and fusion, was affected by the Syt VII
C2A domain. CHO cells were transfected with GFPv, Syt I
C2A–GFP, and Syt VII C2A–GFP and infected with the
protozoan parasite T. gondii or the enteric bacterial patho-
gen S. typhimurium. Toxoplasma enters mammalian cells by
a motility-based mechanism, generating a plasma mem-
brane–derived parasitophorous vacuole that does not fuse
with lysosomes (27). Salmonella triggers extensive actin po-
lymerization and membrane ruffling in host cells, being in-
ternalized in macropinocytic vacuoles (26). No significant
difference in T. gondii invasion levels was detected among
cells expressing the three different constructs (P 5 0.8484;
Fig. 3 B). In the S. typhimurium invasion assays, a margin-
ally significant (P 5 0.0526) enhancement in the number
of intracellular bacteria (reproducible in several experi-
ments) was observed in cells transfected with Syt VII C2A–
GFP (Fig. 3 C). These findings thus indicate that the
mechanism by which Syt VII C2A reduces host cell suscep-
Table I. Expression Levels of GFP and Synaptotagmin 
C2A–GFP Constructs in Transiently Transfected CHO Cells 
Average intensity SD Intensity range
GFPv 30.7 15.8 14.9–46.5
Syt I C2A 38.5 17.3 21.2–55.8
Syt VII C2A 26.2 13.3 12.9–39.5
Syt VIII C2A 28.1 16.3 11.8–44.4
Syt IX C2A 20.0 10.3 9.7–30.3
mSyt VII C2A 29.9 18.2 11.7–48.1
Average fluorescence intensity values correspond to the means of
measurements made on images of 40 individual transfected cells, as
detailed in Materials and Methods. Background values (subtracted from
each fluorescence intensity value) were 22.4 6 0.5 for cells expressing
synaptotagmin C2A–GFP constructs and 25.9 6 1.1 for cells expressing
the pEGFP-N2 vector alone (GFPv).
Figure 3. Expression of the
Syt VII C2A domain inhibits cell
invasion by T. cruzi but not by T.
gondii or S. typhimurium. (A) T.
cruzi invasion of CHO cells un-
transfected (gray bars; unt) or
transfected (white bars) with
GFPv, Syt I C2A–GFP, and Syt
VII C2A–GFP. (B) T. gondii in-
vasion of CHO cells transfected
with GFPv, Syt I C2A–GFP, and
Syt VII C2A–GFP. (C) S. ty-
phymurium invasion of CHO cells
transfected with GFPv, Syt I
C2A–GFP, and Syt VII C2A–
GFP. The data is expressed as the
mean  6 SD of triplicate infec-
tions. The color images below
panels A, B, and C illustrate the
immunofluorescence detection
assays used to distinguish intracel-
lular and extracellular pathogens:
GFP is shown in green, antibod-
ies against T. cruzi, Toxoplasma,
or  Salmonella  in red, and DAPI
DNA stain in blue. Arrows point
to extracellular organisms and ar-
rowheads to intracellular ones.1102 Cell Entry by Trypanosoma cruzi Is Regulated by Synaptotagmin VII
tibility to infection by T. cruzi is specific for this parasite’s
invasion strategy and probably directly related to the regu-
latory role of Syt VII on Ca21-dependent fusion of lyso-
somes with the plasma membrane (8).
A similar inhibitory effect of Syt VII C2A on T. cruzi in-
vasion of z50% was observed in NRK cells transfected
with Syt VII C2A–GFP constructs (Fig. 4 A). These resid-
ual levels of  parasite entry, also observed in CHO cells
loaded with anti–Syt VII C2A antibodies (Fig. 2 C) or
transfected with Syt VII C2A constructs (Fig. 3 A), could
be attributed to either an incomplete inhibition of Syt VII
function or to an alternative invasion pathway. Several lines
of evidence indicate that an incomplete inhibition of Syt
VII function is responsible for this observation. In strong
support of this view, when NRK cells were microinjected
with his-tagged Syt VII C2A domain constructs, a markedly
stronger inhibition in parasite entry (of z70%) was ob-
served when compared with cells microinjected with Syt I
C2A (Fig. 4 B). Similar results were obtained with microin-
jected CHO cells (not shown). These observations suggest
that intracellular concentrations of Syt VII C2A higher than
those reached in transiently transfected cells were probably
achieved by microinjection. Earlier studies demonstrated
that concentrations of Syt VII C2A as high as 200 mg/ml
are required for 80–90% inhibition of lysosome exocytosis
in permeabilized NRK cells (8).
Because invasion experiments cannot be performed with
permeabilized cells (high K1-containing intracellular buff-
ers adversely affect trypomastigotes) and it is not possible to
precisely determine the intracellular concentration of solu-
ble constructs microinjected or expressed in intact cells, we
investigated whether the residual invasion observed in Syt
VII C2A–transfected cells had the hallmarks of lysosome-
mediated entry, extensively characterized previously in our
laboratory (2). All results indicated that this is the case (not
shown). First, the intracellular trypomastigotes found in Syt
VII C2A–transfected cells after short infection periods were
inside intracellular compartments containing the lysosomal
markers Syt VII and Lamp-1. Second, when the actin cy-
toskeleton of host cells was disrupted by pretreatment with
cytochalasin D, invasion levels of cells expressing GFPv,
Syt I–GFP, or Syt VII–GFP were equally increased in
z50–60%. Such enhanced susceptibility to T. cruzi infec-
tion after cytochalasin D treatment was previously de-
scribed in several cell types and functionally correlated with
facilitated lysosome recruitment and fusion (2, 7). This
finding clearly rules out a phagocytic, actin-based alterna-
tive invasion mechanism. Third, the intracellular parasites
escaped normally from the acidified lysosome-derived vac-
uoles and replicated in the cytosol (28), regardless of the
presence of expressed GFP, Syt I C2A–GFP, or Syt VII
C2A–GFP in the cells.
In spite of extensive similarity, characteristic sequence
differences exist between the C2A domains of Syt I and Syt
VII (11, 17). Our present and previous (8) results also re-
vealed important functional differences between these do-
mains. The inhibitory effect of Syt VII C2A and not of Syt
I C2A on both T. cruzi invasion and lysosome exocytosis
may be related to the previously reported distinct proper-
ties exhibited by recombinant forms of these isoforms on
protein binding assays. Recombinant Syt I was reported to
require Ca21 concentrations in the 200 mM range for bind-
ing to syntaxin in vitro, whereas Syt VII–syntaxin interac-
tions were detected at Ca21 concentrations below 10 mM
(11). Interestingly, exocytosis of lysosomes, which is specif-
ically inhibited by the C2A domain of Syt VII, is also trig-
gered at low micromolar [Ca21 ]i (8, 21). A similar differ-
ential requirement for [Ca21] was also reported recently for
the interaction of distinct synaptotagmin isoforms with
SNAP-25 (12). In addition, Ca21-dependent oligomeriza-
tion has been recently proposed to play a central role in the
regulation of exocytosis by synaptotagmins (29–31).
To further test the specificity of the inhibitory effect of
Syt VII C2A, we investigated whether the C2A domains of
additional synaptotagmin isoforms endogenously expressed
in these cells also influenced T. cruzi entry. Specific primers
were designed to amplify the C2A domains of Syt I, II, III,
VI, VII, VIII, and IX from NRK and CHO cell mRNA
by RT-PCR. In addition to Syt VII, only the C2A do-
mains of Syt VIII and Syt IX were specifically detected.
And as expected, the C2A domain of the synaptic vesicle–
specific isoform Syt I, which is very abundantly expressed
in the brain (11), was not amplified from NRK or CHO
cell mRNA. Syt VIII was previously detected in several
different tissues and defined as a ubiquitously expressed iso-
form (11, 14). Specific amino acid substitutions that abolish
Figure 4. The inhibitory effect on T. cruzi invasion is specific for Syt
VII and is abolished by mutation of critical C2A domain residues. The
number of intracellular trypomastigotes was quantitated after infection of:
(A) NRK cells transfected with GFPv (pEGFP-N2 vector alone), Syt I
C2A–GFP, or Syt VII C2A–GFP; (B) NRK cells microinjected with his-
tagged Syt I C2A or Syt VII C2A; (C) CHO cells transfected with GFPv or
GFP-fused C2A domains of the synaptotagmin isoforms Syt I, VII, IX, or
VIII; (D) CHO cells transfected with GFPv, Syt VII C2A–GFP, or mSyt
VII C2A. The data is expressed as the mean 6 SD of triplicate infections.1103 Caler et al. Brief Definitive Report
Ca21 binding were identified in the C2A domain of Syt
VIII, consistent with the lack of Ca21-dependent binding
of this domain to either phospholipids or syntaxin (11, 17,
32). Very little is known about the Syt IX isoform (also re-
ferred to as Syt V [reference 14]), except that it appears to
be expressed in nonneuronal cells, consistent with our find-
ings (33). When T. cruzi invasion assays were performed in
CHO cells transiently transfected with C2A–GFP fusion
constructs of Syt I, VII, VIII, and IX, only the Syt VII C2A
domain had a significant inhibitory effect on parasite entry
(extremely significant: P , 0.0001; Fig. 4 C). The expres-
sion levels of all constructs, as determined from the GFP
cytosolic fluorescence intensity, were within a similar range
(Table I).
The results described above strongly suggested that the
C2A domain of Syt VII has unique properties responsible
for both the modulation of T. cruzi entry and Ca21-depen-
dent exocytosis of lysosomes (8). Although the structure of
the Syt VII C2A domain has not yet been solved, the struc-
ture of the Syt I C2A domain is known to consist of an in-
dependently folded, eight-stranded b sandwich formed by
two four-stranded antiparallel b sheets (34). Structural and
biochemical studies showed that Ca21 ions bind at the top
of the b sandwich, through five clustered aspartic acid resi-
dues, conserved in several Syt isoforms. Interaction with
Ca21 does not lead to conformational changes on the C2A
domain of Syt I but instead causes a marked change in the
molecule’s electrostatic potential, increasing its affinity for
effector molecules such as syntaxin and phospholipids (10).
It has also been suggested that the unique electrostatic
properties of synaptotagmins may allow a positively
charged, polybasic region present at the center of both the
C2A and C2B domains to interact with the negatively
charged surface at the core of the SNARE complex, facili-
tating membrane fusion (35). Indeed, recent studies dem-
onstrated that the polybasic KKKK motif at residues 189–
192 of the C2A domain of Syt I plays a central role in the
regulation of Ca21-triggered exocytosis in PC12 cells. Re-
placement of these residues by alanines did not interfere
with proper folding of the C2A domain, as indicated by
normal interaction with syntaxin and phospholipids in
vitro, but reduced its inhibitory activity in dense core gran-
ule secretion assays (20). We found that recombinant Syt
VII C2A constructs containing mutations either in the cor-
responding polybasic motif (K183,184A/H185A/K186A)
or in the putative Ca21-binding aspartic acid residues
(D166,172,225,227N) were still inhibitory in b-hex-
osaminidase secretion assays with streptolysin O–permeabi-
lized NRK cells (unpublished data), reinforcing the con-
clusion that these amino acid replacements do not appear
to interfere with proper folding of the Syt VII C2A do-
main. The lack of reduced inhibitory activity after these
mutations was not surprising, considering the variation in
sequence between the polybasic motif of Syt I and Syt VII
C2A (11), and particularly in view of recent findings indi-
cating that functional Ca21-binding sites remain in Syt I af-
ter mutation of Ca21-coordinating aspartic acid residues
(36). Interestingly, however, when both sets of mutations
(K183,184A/H185A/K186A and D166,172,225,227N)
were combined, the inhibitory activity of Syt VII C2A in
b-hexosaminidase secretion assays was completely abol-
ished (unpublished data). We therefore cloned this con-
struct with both sets of mutations into the pEGFP-N2 ex-
pression vector and analyzed its effect in T. cruzi invasion
assays with transiently transfected CHO cells. Cells express-
ing GFP alone, wild-type Syt VII C2A–GFP, and mSyt VII
C2A within a similar range of fluorescence intensity (Table
I) were analyzed for the presence of intracellular T. cruzi.
As shown in Fig. 4 D, the specific amino acid substitutions
on Syt VII C2A abolished its inhibitory effect on cell inva-
sion by T. cruzi, confirming that the mutated residues play
similarly important roles in the regulation of lysosomal
exocytosis and of T. cruzi entry.
Additional studies are required to define the regions of
the Syt VII C2A domain responsible for its unique proper-
ties in the regulation of Ca21-dependent fusion of lyso-
somes with the plasma membrane. The finding that modu-
lation of Syt VII function affects both Ca21-regulated
exocytosis of lysosomes and the ability of T. cruzi trypo-
mastigotes to enter host cells provides, for the first time, a
molecular basis for the unusual, lysosome-dependent inva-
sion mechanism of this important pathogen. Taken to-
gether, our results strongly suggest that T. cruzi subverts the
Ca21-regulated lysosomal exocytic machinery involving
Syt VII, which is present in a variety of cell types, as a strat-
egy for cell entry.
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